Literature DB >> 3936083

Effect of the experimental antidepressant AHR-9377 on performance during differential reinforcement of low response rate.

J M O'Donnell, L S Seiden.   

Abstract

The effect of acute administration of AHR-9377 on performance under a differential-reinforcement-of-low-rate 72-s (DRL 72-s) schedule was assessed. AHR-9377 reduced response rates and increased reinforcement rates of rats responding under the DRL 72-s schedule; these effects were similar to those of established antidepressant drugs. AHR-9377 also decreased the time of immobility in the forced-swimming test, an empirical model of depression. These results are consistent with the contention that AHR-9377 possesses antidepressant activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936083     DOI: 10.1007/bf00432708

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  A COMPARISON OF THE EFFECTS OF DESIPRAMINE AND IMIPRAMINE ON TWO SCHEDULES OF REINFORCEMENT.

Authors:  C KORNETSKY
Journal:  Int J Neuropharmacol       Date:  1965-02

2.  Non-specificity of "behavioral despair" as an animal model of depression.

Authors:  M D Schechter; W T Chance
Journal:  Eur J Pharmacol       Date:  1979-12-07       Impact factor: 4.432

3.  Depression: a new animal model sensitive to antidepressant treatments.

Authors:  R D Porsolt; M Le Pichon; M Jalfre
Journal:  Nature       Date:  1977-04-21       Impact factor: 49.962

4.  Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate.

Authors:  J M O'Donnell; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rates schedule in rats.

Authors:  P S McGuire; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1980-09       Impact factor: 4.030

6.  Profile of drug effects on temporally spaced responding in rats.

Authors:  K Ando
Journal:  Pharmacol Biochem Behav       Date:  1975 Sep-Oct       Impact factor: 3.533

7.  The existence of tolerance to and cross-tolerance between d-amphetamine and methylphenidate for their effects on milk consumption and on differential-reinforcement-of-low-rate performance in the rat.

Authors:  R G Pearl; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

8.  Differential effects of imipramine in rats as a function of DRL schedule value.

Authors:  P S McGuire; L S Seiden
Journal:  Pharmacol Biochem Behav       Date:  1980-11       Impact factor: 3.533

9.  Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule.

Authors:  L S Seiden; J L Dahms; R A Shaughnessy
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs.

Authors:  J M O'Donnell; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

  10 in total
  3 in total

1.  The effect of changes in criterion value on differential reinforcement of low rate schedule performance.

Authors:  Matthew J Pizzo; Kimberly Kirkpatrick; Pamela J Blundell
Journal:  J Exp Anal Behav       Date:  2009-09       Impact factor: 2.468

2.  Continuous time estimation as a behavioural index of human cerebral ischaemia during temporary occlusion of the internal carotid artery.

Authors:  R M Lazar; R S Marshall; J Pile-Spellman; W L Young; L Hacein-Bey; R P Sloan; J P Mohr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

3.  A quantitative interresponse-time analysis of DRL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone.

Authors:  J B Richards; L S Seiden
Journal:  J Exp Anal Behav       Date:  1991-09       Impact factor: 2.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.